Literature DB >> 17848272

Gene expression profiles as markers of aggressive disease-EGFR as a factor.

Christine H Chung1, Joel Parker, Shawn Levy, Robbert J Slebos, Adam P Dicker, Ulrich Rodeck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17848272      PMCID： PMC2361130          DOI： 10.1016/j.ijrobp.2007.05.039

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  13 in total

1.  Real time quantitative PCR.

Authors:  C A Heid; J Stevens; K J Livak; P M Williams
Journal:  Genome Res       Date:  1996-10       Impact factor: 9.043

2.  Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments.

Authors:  J Albanell; J Codony-Servat; F Rojo; J M Del Campo; S Sauleda; J Anido; G Raspall; J Giralt; J Roselló; R I Nicholson; J Mendelsohn; J Baselga
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

3.  Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer.

Authors:  Bin-Bing S Zhou; Michael Peyton; Biao He; Changnian Liu; Luc Girard; Eian Caudler; Yvonne Lo; Frederic Baribaud; Iwao Mikami; Noemi Reguart; Gengjie Yang; Yanlong Li; Wenqing Yao; Kris Vaddi; Adi F Gazdar; Steven M Friedman; David M Jablons; Robert C Newton; Jordan S Fridman; John D Minna; Peggy A Scherle
Journal:  Cancer Cell       Date:  2006-07       Impact factor: 31.743

Review 4.  ErbB-targeted therapeutic approaches in human cancer.

Authors:  Carlos L Arteaga
Journal:  Exp Cell Res       Date:  2003-03-10       Impact factor: 3.905

Review 5.  Targeting HER1/EGFR: a molecular approach to cancer therapy.

Authors:  Carlos Arteaga
Journal:  Semin Oncol       Date:  2003-06       Impact factor: 4.929

6.  Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

Authors:  J Rubin Grandis; M F Melhem; W E Gooding; R Day; V A Holst; M M Wagener; S D Drenning; D J Tweardy
Journal:  J Natl Cancer Inst       Date:  1998-06-03       Impact factor: 13.506

7.  Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression.

Authors:  Christine H Chung; Joel S Parker; Gamze Karaca; Junyuan Wu; William K Funkhouser; Dominic Moore; Dale Butterfoss; Dong Xiang; Adam Zanation; Xiaoying Yin; William W Shockley; Mark C Weissler; Lynn G Dressler; Carol G Shores; Wendell G Yarbrough; Charles M Perou
Journal:  Cancer Cell       Date:  2004-05       Impact factor: 31.743

8.  Complex regulation of signal transducers and activators of transcription 3 activation in normal and malignant keratinocytes.

Authors:  Marlene R D Quadros; Francesca Peruzzi; Csaba Kari; Ulrich Rodeck
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

9.  Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3.

Authors:  Natalia V Sergina; Megan Rausch; Donghui Wang; Jimmy Blair; Byron Hann; Kevan M Shokat; Mark M Moasser
Journal:  Nature       Date:  2007-01-07       Impact factor: 49.962

10.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.

Authors:  P Boukamp; R T Petrussevska; D Breitkreutz; J Hornung; A Markham; N E Fusenig
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539
View more
  3 in total

1.  Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition.

Authors:  Natalie R Young; Jing Liu; Carolyn Pierce; Tai-Fen Wei; Tatyana Grushko; Olufunmilayo I Olopade; Wanqing Liu; Christine Shen; Tanguy Y Seiwert; Ezra E W Cohen
Journal:  Mol Oncol       Date:  2012-11-14       Impact factor: 6.603

2.  Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma.

Authors:  Elana J Fertig; Qing Ren; Haixia Cheng; Hiromitsu Hatakeyama; Adam P Dicker; Ulrich Rodeck; Michael Considine; Michael F Ochs; Christine H Chung
Journal:  BMC Genomics       Date:  2012-05-01       Impact factor: 3.969

3.  Implication of stem cells in the biology and therapy of head and neck cancer.

Authors:  Barbara Wollenberg
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.